6 completed. 4 Not applicable, 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 4 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Stage IIA Skin Melanoma: new trials by email Literature Review of Stage IIA Skin Melanoma trials Research Report on Stage IIA Skin Melanoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma Internet-Based Intervention, Questionnaire Administration, Survey Administration - Stage 0 Skin Melanoma, Stage I Skin Melanoma | Not applicable | Completed | Rutgers, The State University of New Jersey | 485 | 2017-01-13 | 2026-01-14 |
| Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy Diagnostic Microscopy, Fluorescein Sodium Injection, Laboratory Biomarker Analysis - Stage IB Skin Melanoma, Stage IIA Skin Melanoma | Not applicable | Completed | Roswell Park Cancer Institute | 20 | 2016-11-03 | 2022-08-01 |
| MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery MART-1 Antigen, TLR4 Agonist GLA-SE, Laboratory Biomarker Analysis - Stage IIA Skin Melanoma, Stage IIB Skin Melanoma | Early Phase 1 | Completed | Mayo Clinic | 23 | 2015-01-27 | 2020-01-14 |
| Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery Diagnostic Microscopy, Fluorescein Sodium Injection, Laboratory Biomarker Analysis - Recurrent Melanoma, Stage IA Skin Melanoma | Not applicable | Completed | Roswell Park Cancer Institute | 10 | 2013-09-04 | 2020-08-07 |
| Recombinant Interferon Alfa-2b in Treating Patients With Melanoma recombinant interferon alfa-2b, laboratory biomarker analysis - Stage IA Skin Melanoma, Stage IB Skin Melanoma | Not applicable | Completed | William Carson | 34 | 2008-04-22 | 2018-11-02 |
| Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery gp100:209-217(210M) Peptide Vaccine, HPV 16 E7:12-20 Peptide Vaccine, Laboratory Biomarker Analysis - Recurrent Melanoma, Stage IA Skin Melanoma | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2002-10-01 | 2015-01-26 |
Melanoma (6)
Neoplasms (6) · Neoplasms by Histologic Type (6) · Neoplasms by Site (6) · Neoplasms, Germ Cell and Embryonal (6) · Neoplasms, Nerve Tissue (6) · Neuroectodermal Tumors (6) · Neuroendocrine Tumors (6) · Nevi and Melanomas (6) · Skin Diseases (6) · Skin Neoplasms (6) · Skin and Connective Tissue Diseases (6)
Fluorescein (2) · Fluoresceins (1) · Introns (1) · MART-1 Antigen (1) · Peptides (1) · Protein Subunit Vaccines (1) · Sentinel Lymph Node Biopsy (1) · glucopyranosyl lipid-A (1)
Roswell Park Cancer Institute (2) · Mayo Clinic (1) · National Cancer Institute (NCI) (1) · Rutgers, The State University of New Jersey (1) · William Carson (1)
United States (6)
Joseph Skitzki (2) · Elliot Coups (1) · Matthew Block (1) · Walter Urba (1) · William Carson, MD (1)
PMID 31255801, PMID 32752904, PMID 33955240
P30CA015083 (1), P30CA016056 (1), R01CA171666 (1), R21CA099265 (1)